# Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache

> **NCT01842633** · PHASE3 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 365 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Paracetamol and Caffeine
- **DRUG:** Ibuprofen
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01842633
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04-01
- **Primary completion:** 2015-03-31
- **Final completion:** 2015-03-31
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842633, "Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01842633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*